LDL-apheresis therapy of hyperlipidemia
Lee, Y.J.
Nihon Rinsho. Japanese Journal of Clinical Medicine 48(11): 2629-2635
1990
ISSN/ISBN: 0047-1852 PMID: 2270031 Document Number: 349412
Document emailed within 1 workday
Related Documents
Stefanutti, C.; Di Giacomo, S.; Morozzi, C. 2012: LDL apheresis: an update and overview. LDL apheresis in Sardinia, Italy (SMILDLa) Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 29 Suppl. 54: S14-S18Rózański, J. 2000: The effect of hyperlipidemia on metabolism, distribution and secretion of lidocaine in patients with primary hyperlipidemia Annales Academiae Medicae Stetinensis 46: 177-187
Kajiyama, G.; Horiuchi, I. 1990: Drug therapy of hyperlipidemia Nihon Rinsho. Japanese Journal of Clinical Medicine 48(11): 2620-2628
Hedge, D. 1993: Drug therapy for hyperlipidemia South Dakota Journal of Medicine 46(7): 234-235
Ames, R. 1998: Hyperlipidemia of diuretic therapy Archives des Maladies du Coeur et des Vaisseaux 91 Suppl: 23-27
Rose, H.D.; Roth, D.A.; Barboriak, J.J. 1979: Hyperlipidemia related to miconazole therapy Annals of Internal Medicine 91(3): 491-492
Ladodo, K.S.; Kniazev, I.A.; Lebed'kova, S.E.; Turkina, T.I.; Belova, O.K. 1987: Diet therapy of hyperlipidemia in children Voprosy Pitaniia 2: 20-23
Umeda, T.; Sato, T.; Hamasaki, S.; Fujimoto, Y. 1992: Antihypertensive therapy of the patients with hyperlipidemia Nihon Rinsho. Japanese Journal of Clinical Medicine 50 Suppl: 211-217
Jordan, R.M. 1987: Pathogenesis, evaluation and therapy of hyperlipidemia Journal of the Arkansas Medical Society 84(1): 59-64
McCarter, T.L.; Chen, Y.K. 1992: Marked hyperlipidemia and pancreatitis associated with isotretinoin therapy American Journal of Gastroenterology 87(12): 1855-1858
Honjo, H.; Tanaka, K. 1999: Efficacy of hormone replacement therapy on hyperlipidemia Nihon Rinsho. Japanese Journal of Clinical Medicine 57(12): 2848-2853
Kobori, S. 2002: Medical therapy corresponding to the morbid state of hyperlipidemia Nihon Rinsho. Japanese Journal of Clinical Medicine 60(5): 948-954
Koletzko, B.; Herzog, M. 1998: Hyperlipidemia in children and adolescents: diagnosis and therapy Schweizerische Medizinische Wochenschrift 128(13): 477-485
Avellone, G.; Di Garbo, V.; Strano, A. 1989: Therapy of hyperlipidemia. Clinical experience with clinofibrate La Clinica Terapeutica 129(1): 25-29
Hayakawa, A. 2001: Estrogen progestogen replacement therapy for hyperlipidemia in postmenopausal women Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 3): 701-706
Micić, D.; Ivković-Lazar, T.; Dragojević, R.; Jorga, J.; Stokić, E.; Hajduković, Z. 1999: Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia Medicinski Pregled 52(9-10): 323-333
Bittar, A.E.; Ratcliffe, P.J.; Richardson, A.J.; Raine, A.E.; Jones, L.; Yudkin, P.L.; Carter, R.; Mann, J.I.; Morris, P.J. 1990: The prevalence of hyperlipidemia in renal transplant recipients. Associations with immunosuppressive and antihypertensive therapy Transplantation 50(6): 987-992
Honjo, H.; Urabe, M. 1996: Hormone replacement therapy (HRT) and hyperlipidemia: effect of HRT on serum lipids and it's atheroprotective function Nihon Sanka Fujinka Gakkai Zasshi 48(8): 694-707
Müting, D. 1978: Metabolic risk factors and their field of action. Incidence and therapy of hypertension, hyperuricemia, hyperlipidemia, diabetes mellitus, nicotine and alcohol abuse and obesity Fortschritte der Medizin 96(25): 1319-1322
Kłosiewicz-Latoszek, L.; Respondek, W.; Białobrzeska-Paluszkiewicz, J.; Grzybowska, B.; Jakóbisiak-Ostasz, B.; Stolarska, I. 2003: Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 15(85): 42-46